Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca gets rights to 2 Nektar pain drug candidates in deal valued at about $1.12B
AstraZeneca gets rights to 2 Nektar pain drug candidates in deal valued at about $1.12B
AstraZeneca gets rights to 2 Nektar pain drug candidates in deal valued at about $1.12B
Submitted by
admin
on September 21, 2009 - 9:57am
Source:
Yahoo/AP
News Tags:
AstraZeneca
Nektar
Headline:
AstraZeneca gets rights to 2 Nektar pain drug candidates in deal valued at about $1.12B
Do Not Allow Advertisers to Use My Personal information
